Management of Heart Failure in Primary Care and the use of Forxiga (dapagliflozin) - Questions and Answers
AstraZeneca have provided financial support for this blended learning series and have had no involvement in the content or speaker selection
Dr Jim Moore and Dr Derek Connolly broadcasted a live webinar on 20th May on behalf of the PCCS.
They focused on key diagnostic assessments that would be expected in a primary care setting and discussed the available treatment options for HFrEF.
They examined when dapagliflozin would be suitable based on its new licenced indication and provided a narrative on the Cardiovascular Outcome Trials (CVOT) and the development of dapagliflozin in the treatment of HFrEF.
They also reviewed the NICE guidance for dapagliflozin in HFrEF including commenting on which patients it would be appropriate to treat with dapagliflozin.
The Question and Answer sheet contains delegate questions which were not answered during the live webinar due to time constraints.
The entire webinar including additional questions that were answered and discussed during the session can be viewed here: